View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Search Results for AVI BioPharma Inc

Results 1 - 4

Refine Search

Display Mode: Context | Summary

Beacon Equity Research on Stocks to Watch: AVI BioPharma, Coeur d'Alene, Alcoa, Oncothyreon, Verizon and Toyota

2009 JUL 6 ... for free by visiting BeaconEquity.com/m. Today's Stock Alerts include: AVI BioPharma Inc. (NASDAQ:AVII), Coeur d'Alene Mines Corp. (NYSE:CDE), Alcoa Inc. (NYSE:AA), ...

Subject: BeaconEquity.com

Price: $3.00

Studies from AVI BioPharma, Inc., Department of Biology provide new data on dermatitis gene therapy

2009 JUL 27 ... 2009;129(8):1945-53). For additional information, contact D.V. Mourich, AVI BioPharma Inc., Dept. of Biology, Corvallis, Oregon USA.. The publisher's contact ...

Subject: Dermatitis Gene Therapy

Price: $3.00

SuperGen Reports 2009 Second Quarter Financial Results

2009 AUG 10 ... reflects an other than temporary decline in value in the Company's equity investment in AVI BioPharma. There was no similar non-operating charge in the 2009 second quarter. ... SuperGen, Inc. (NASDAQ:SUPG) reported financial results for the second quarter and six months ended ...

Subject: SuperGen, Inc.

Price: $3.00

This Essential Global Strategic Business Report on Bioterrorism Provides a Comprehensive Analysis and Annual Forecasts Through to 2015

2009 JUL 27 ... 66 companies including many key and niche players worldwide such as Acambis Plc., AVI BioPharma, Inc., Blucher Gmbh, Evogen, Inc., Human Genome Sciences Inc., ICX ...

Subject: Research and Markets Ltd.

Price: $3.00

Results 1 - 4


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx